INTRODUCTION: Oral squamous cell carcinoma (OSCC) is a prevalent and deadly cancer, with over 350,000 new cases yearly. A hypoxic tumor microenvironment is the bottleneck of photodynamic therapy (PDT) and significantly weakens overall therapeutic efficacy. METHODS: In this study, we introduce nitrogen vacancy-modified PCN (N(V)-PCN), a novel metal-free and O(2)-independent photosensitizer designed for PDT. N(V)-PCN targets Cal-27-induced OSCC by reducing highly expressed H(2)O(2) in tumors to highly reactive â¢OH. This innovative approach aims to overcome the limitations posed by the hypoxic environment and enhance the effectiveness of PDT in treating OSCC. RESULTS: The introduction of N(V) not only further improves the cell accessibility of PCN by increasing the content of -NH(2) but also provides more reactive sites for H(2)O(2) reduction and facilitates carrier separation. Under illumination, N(V)-PCN generates a burst of â¢OH around the nuclei and mitochondria of Cal-27 cells, which effectively kills the cells via synchronously leading to DNA damage and mitochondrial dysfunction. Compared to the conventional photosensitizer chlorin e6, N(V)-PCN-based PDT exhibits excellent anticancer performance in vitro and in vivo, highlighting its potential as a next-generation therapeutic agent. CONCLUSION: Collectively, the high â¢OH-generation efficiency, strong anticancer activity, and overall safety of the O(2)-independent nanoparticle opens up new avenues for in-depth study on carbon nitride-based cancer PDT strategies. This work offers new hope for the effective treatment of OSCC and other challenging cancers.
Boosting Hydroxyl Radical Generation with Nitrogen Vacancy-Modified Carbon Nitride for Triggering Dual Damage of Cancer Nucleus DNA-Mitochondria against Hypoxic Tumors.
利用氮空位修饰的碳氮化物增强羟基自由基的生成,从而触发癌细胞核DNA-线粒体的双重损伤,对抗缺氧肿瘤
阅读:4
作者:Zhang Yuan, Liu Meixian, Xue Shuyun, Li Na, Hong Jinjia, Gu Jiawen, Ren Xiaoyan, Li Huifei, Xu Jie, Zhang Chengxi, Liang Tianqi, Zhao Bin, Wang Xing
| 期刊: | International Journal of Nanomedicine | 影响因子: | 6.500 |
| 时间: | 2025 | 起止号: | 2025 Jul 5; 20:8765-8781 |
| doi: | 10.2147/IJN.S515726 | 研究方向: | 肿瘤 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
